Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989]
更正“识别激素受体阳性/HER2阴性乳腺癌新辅助化疗和内分泌治疗引起的治疗反应和分子变化的预测因子:NEOENDO转化研究”:[ESMO Open 9 (2024) 103989]
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105328
Schettini, F; Brasó-Maristany, F; Pascual, T; Lorman-Carbó, N; Nucera, S; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rodríguez, A B; Martínez-Sáez, O; Chic, N; Vidal, M; Adamo, B; González-Farre, B; Sanfeliu, E; Cebrecos, I; Mensión, E; Oses, G; Locci, M; Mollà, M; Ganau, S; Jares, P; Vidal-Sicart, S; Muñoz, M; Prat, A
SMO
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌